{
    "title": "Drug Addiction Treatment Act of 2000",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Drug Addiction Treatment Act of \n2000''.\n\nSEC. 2. AMENDMENT TO CONTROLLED SUBSTANCES ACT.\n\n    (a) In General.--Section 303(g) of the Controlled Substances Act \n(21 U.S.C. 823(g)) is amended--\n            (1) in paragraph (2), by striking ``(A) security'' and \n        inserting ``(i) security'', and by striking ``(B) the \n        maintenance'' and inserting ``(ii) the maintenance'';\n            (2) by redesignating paragraphs (1) through (3) as \n        subparagraphs (A) through (C), respectively;\n            (3) by inserting ``(1)'' after ``(g)'';\n            (4) by striking ``Practitioners who dispense'' and \n        inserting ``Except as provided in paragraph (2), practitioners \n        who dispense''; and\n            (5) by adding at the end the following paragraph:\n    ``(2)(A) Subject to subparagraphs (D) and (J), the requirements of \nparagraph (1) are waived in the case of the dispensing (including the \nprescribing), by a practitioner, of narcotic drugs in schedule III, IV, \nor V or combinations of such drugs if the practitioner meets the \nconditions specified in subparagraph (B) and the narcotic drugs or \ncombinations of such drugs meet the conditions specified in \nsubparagraph (C).\n    ``(B) For purposes of subparagraph (A), the conditions specified in \nthis subparagraph with respect to a practitioner are that, before the \ninitial dispensing of narcotic drugs in schedule III, IV, or V or \ncombinations of such drugs to patients for maintenance or \ndetoxification treatment, the practitioner submit to the Secretary a \nnotification of the intent of the practitioner to begin dispensing the \ndrugs or combinations for such purpose, and that the notification \ncontain the following certifications by the practitioner:\n            ``(i) The practitioner is a qualifying physician (as \n        defined in subparagraph (G)).\n            ``(ii) With respect to patients to whom the practitioner \n        will provide such drugs or combinations of drugs, the \n        practitioner has the capacity to refer the patients for \n        appropriate counseling and other appropriate ancillary \n        services.\n            ``(iii) In any case in which the practitioner is not in a \n        group practice, the total number of such patients of the \n        practitioner at any one time will not exceed the applicable \n        number. For purposes of this clause, the applicable number is \n        30, except that the Secretary may by regulation change such \n        total number.\n            ``(iv) In any case in which the practitioner is in a group \n        practice, the total number of such patients of the group \n        practice at any one time will not exceed the applicable number. \n        For purposes of this clause, the applicable number is 30, \n        except that the Secretary may by regulation change such total \n        number, and the Secretary for such purposes may by regulation \n        establish different categories on the basis of the number of \n        practitioners in a group practice and establish for the various \n        categories different numerical limitations on the number of \n        such patients that the group practice may have.\n    ``(C) For purposes of subparagraph (A), the conditions specified in \nthis subparagraph with respect to narcotic drugs in schedule III, IV, \nor V or combinations of such drugs are as follows:\n            ``(i) The drugs or combinations of drugs have, under the \n        Federal Food, Drug, and Cosmetic Act or section 351 of the \n        Public Health Service Act, been approved for use in maintenance \n        or detoxification treatment.\n            ``(ii) The drugs or combinations of drugs have not been the \n        subject of an adverse determination. For purposes of this \n        clause, an adverse determination is a determination published \n        in the Federal Register and made by the Secretary, after \n        consultation with the Attorney General, that the use of the \n        drugs or combinations of drugs for maintenance or \n        detoxification treatment requires additional standards \n        respecting the qualifications of practitioners to provide such \n        treatment, or requires standards respecting the quantities of \n        the drugs that may be provided for unsupervised use.\n    ``(D)(i) A waiver under subparagraph (A) with respect to a \npractitioner is not in effect unless (in addition to conditions under \nsubparagraphs (B) and (C)) the following conditions are met:\n            ``(I) The notification under subparagraph (B) is in writing \n        and states the name of the practitioner.\n            ``(II) The notification identifies the registration issued \n        for the practitioner pursuant to subsection (f).\n            ``(III) If the practitioner is a member of a group \n        practice, the notification states the names of the other \n        practitioners in the practice and identifies the registrations \n        issued for the other practitioners pursuant to subsection (f).\n    ``(ii) Upon receiving a notification under subparagraph (B), the \nAttorney General shall assign the practitioner involved an \nidentification number under this paragraph for inclusion with the \nregistration issued for the practitioner pursuant to subsection (f). \nThe identification number so assigned clause shall be appropriate to \npreserve the confidentiality of patients for whom the practitioner has \ndispensed narcotic drugs under a waiver under subparagraph (A).\n    ``(iii) Not later than 45 days after the date on which the \nSecretary receives a notification under subparagraph (B), the Secretary \nshall make a determination of whether the practitioner involved meets \nall requirements for a waiver under subparagraph (B). If the Secretary \nfails to make such determination by the end of the such 45-day period, \nthe Attorney General shall assign the physician an identification \nnumber described in clause (ii) at the end of such period.\n    ``(E)(i) If a practitioner is not registered under paragraph (1) \nand, in violation of the conditions specified in subparagraphs (B) \nthrough (D), dispenses narcotic drugs in schedule III, IV, or V or \ncombinations of such drugs for maintenance treatment or detoxification \ntreatment, the Attorney General may, for purposes of section 304(a)(4), \nconsider the practitioner to have committed an act that renders the \nregistration of the practitioner pursuant to subsection (f) to be \ninconsistent with the public interest.\n    ``(ii)(I) A practitioner who in good faith submits a notification \nunder subparagraph (B) and reasonably believes that the conditions \nspecified in subparagraphs (B) through (D) have been met shall, in \ndispensing narcotic drugs in schedule III, IV, or V or combinations of \nsuch drugs for maintenance treatment or detoxification treatment, be \nconsidered to have a waiver under subparagraph (A) until notified \notherwise by the Secretary.\n    ``(II) For purposes of subclause (I), the publication in the \nFederal Register of an adverse determination by the Secretary pursuant \nto subparagraph (C)(ii) shall (with respect to the narcotic drug or \ncombination involved) be considered to be a notification provided by \nthe Secretary to practitioners, effective upon the expiration of the \n30-day period beginning on the date on which the adverse determination \nis so published.\n    ``(F)(i) With respect to the dispensing of narcotic drugs in \nschedule III, IV, or V or combinations of such drugs to patients for \nmaintenance or detoxification treatment, a practitioner may, in his or \nher discretion, dispense such drugs or combinations for such treatment \nunder a registration under paragraph (1) or a waiver under subparagraph \n(A) (subject to meeting the applicable conditions).\n    ``(ii) This paragraph may not be construed as having any legal \neffect on the conditions for obtaining a registration under paragraph \n(1), including with respect to the number of patients who may be served \nunder such a registration.\n    ``(G) For purposes of this paragraph:\n            ``(i) The term `group practice' has the meaning given such \n        term in section 1877(h)(4) of the Social Security Act.\n            ``(ii) The term `qualifying physician' means a physician \n        who is licensed under State law and who meets one or more of \n        the following conditions:\n                    ``(I) The physician holds a subspecialty board \n                certification in addiction psychiatry from the American \n                Board of Medical Specialties.\n                    ``(II) The physician holds an addiction \n                certification from the American Society of Addiction \n                Medicine.\n                    ``(III) The physician holds a subspecialty board \n                certification in addiction medicine from the American \n                Osteopathic Association.\n                    ``(IV) The physician has, with respect to the \n                treatment and management of opiate-dependent patients, \n                completed not less than eight hours of training \n                (through classroom situations, seminars at professional \n                society meetings, electronic communications, or \n                otherwise) that is provided by the American Society of \n                Addiction Medicine, the American Academy of Addiction \n                Psychiatry, the American Medical Association, the \n                American Osteopathic Association, the American \n                Psychiatric Association, or any other organization that \n                the Secretary determines is appropriate for purposes of \n                this subclause.\n                    ``(V) The physician has participated as an \n                investigator in one or more clinical trials leading to \n                the approval of a narcotic drug in schedule III, IV, or \n                V for maintenance or detoxification treatment, as \n                demonstrated by a statement submitted to the Secretary \n                by the sponsor of such approved drug.\n                    ``(VI) The physician has such other training or \n                experience as the State medical licensing board (of the \n                State in which the physician will provide maintenance \n                or detoxification treatment) considers to demonstrate \n                the ability of the physician to treat and manage \n                opiate-dependent patients.\n                    ``(VII) The physician has such other training or \n                experience as the Secretary considers to demonstrate \n                the ability of the physician to treat and manage \n                opiate-dependent patients. Any criteria of the \n                Secretary under this subclause shall be established by \n                regulation. Any such criteria are effective only for 3 \n                years after the date on which the criteria are \n                promulgated, but may be extended for such additional \n                discrete 3-year periods as the Secretary considers \n                appropriate for purposes of this subclause. Such an \n                extension of criteria may only be effectuated through a \n                statement published in the Federal Register by the \n                Secretary during the 30-day period preceding the end of \n                the 3-year period involved.\n    ``(H)(i) In consultation with the Administrator of the Drug \nEnforcement Administration, the Administrator of the Substance Abuse \nand Mental Health Services Administration, the Director of the Center \nfor Substance Abuse Treatment, the Director of the National Institute \non Drug Abuse, and the Commissioner of Food and Drugs, the Secretary \nshall issue regulations (through notice and comment rulemaking) or \nissue practice guidelines to address the following:\n            ``(I) Approval of additional credentialing bodies and the \n        responsibilities of additional credentialing bodies.\n            ``(II) Additional exemptions from the requirements of this \n        paragraph and any regulations under this paragraph.\nNothing in such regulations or practice guidelines may authorize any \nFederal official or employee to exercise supervision or control over \nthe practice of medicine or the manner in which medical services are \nprovided.\n    ``(ii) Not later than 120 days after the date of the enactment of \nthe Drug Addiction Treatment Act of 2000, the Secretary shall issue a \ntreatment improvement protocol containing best practice guidelines for \nthe treatment and maintenance of opiate-dependent patients. The \nSecretary shall develop the protocol in consultation with the Director \nof the National Institute on Drug Abuse, the Director of the Center for \nSubstance Abuse Treatment, the Administrator of the Drug Enforcement \nAdministration, the Commissioner of Food and Drugs, the Administrator \nof the Substance Abuse and Mental Health Services Administration, and \nother substance abuse disorder professionals. The protocol shall be \nguided by science.\n    ``(I) During the 3-year period beginning on the date of the \nenactment of the Drug Addiction Treatment Act of 2000, a State may not \npreclude a practitioner from dispensing or prescribing drugs in \nschedule III, IV, or V, or combinations of such drugs, to patients for \nmaintenance of detoxification treatment in accordance with this \nparagraph unless, before the expiration of that 3-year period, the \nState enacts a law prohibiting a practitioner from dispensing such \ndrugs or combinations of drug.\n    ``(J)(i) This paragraph takes effect on the date of the enactment \nof the Drug Addiction Treatment Act of 2000, and remains in effect \nthereafter except as provided in clause (iii) (relating to a decision \nby the Secretary or the Attorney General that this paragraph should not \nremain in effect).\n    ``(ii) For purposes relating to clause (iii), the Secretary and the \nAttorney General may, during the 3-year period beginning on the date of \nthe enactment of the Drug Addiction Treatment Act of 2000, make \ndeterminations in accordance with the following:\n            ``(I) The Secretary may make a determination of whether \n        treatments provided under waivers under subparagraph (A) have \n        been effective forms of maintenance treatment and \n        detoxification treatment in clinical settings; may make a \n        determination of whether such waivers have significantly \n        increased (relative to the beginning of such period) the \n        availability of maintenance treatment and detoxification \n        treatment; and may make a determination of whether such waivers \n        have adverse consequences for the public health.\n            ``(II) The Attorney General may make a determination of the \n        extent to which there have been violations of the numerical \n        limitations established under subparagraph (B) for the number \n        of individuals to whom a practitioner may provide treatment; \n        may make a determination of whether waivers under subparagraph \n        (A) have increased (relative to the beginning of such period) \n        the extent to which narcotic drugs in schedule III, IV, or V or \n        combinations of such drugs are being dispensed or possessed in \n        violation of this Act; and may make a determination of whether \n        such waivers have adverse consequences for the public health.\n    ``(iii) If, before the expiration of the period specified in clause \n(ii), the Secretary or the Attorney General publishes in the Federal \nRegister a decision, made on the basis of determinations under such \nclause, that this paragraph should not remain in effect, this paragraph \nceases to be in effect 60 days after the date on which the decision is \nso published. The Secretary shall in making any such decision consult \nwith the Attorney General, and shall in publishing the decision in the \nFederal Register include any comments received from the Attorney \nGeneral for inclusion in the publication. The Attorney General shall in \nmaking any such decision consult with the Secretary, and shall in \npublishing the decision in the Federal Register include any comments \nreceived from the Secretary for inclusion in the publication.''.\n    (b) Conforming Amendments.--Section 304 of the Controlled \nSubstances Act (21 U.S.C. 824) is amended--\n            (1) in subsection (a), in the matter after and below \n        paragraph (5), by striking ``section 303(g)'' each place such \n        term appears and inserting ``section 303(g)(1)''; and\n            (2) in subsection (d), by striking ``section 303(g)'' and \n        inserting ``section 303(g)(1)''.\n\nSEC. 3. ADDITIONAL AUTHORIZATION OF APPROPRIATIONS REGARDING DEPARTMENT \n              OF HEALTH AND HUMAN SERVICES.\n\n    For the purpose of assisting the Secretary of Health and Human \nServices with the additional duties established for the Secretary \npursuant to the amendments made by section 2, there are authorized to \nbe appropriated, in addition to other authorizations of appropriations \nthat are available for such purpose, such sums as may be necessary for \nfiscal year 2000 and each subsequent fiscal year.\n\n            Passed the House of Representatives July 19, 2000.\n\n            Attest:\n\n                                                 JEFF TRANDAHL,\n\n                                                                 Clerk.\n\n\n\n\n                                                       "
}